Reading Time: 5 minutesBy John Poothullil, MD, FRCP GLP-1 medications such as Ozempic, Wegovy, and Mounjaro have transformed the conversation about obesity and Type 2 diabetes. For many patients, these medications can produce substantial weight loss while improving blood sugar control and other measures of metabolic health. But their growing use raises an important question: Are these medications simply suppressing appetite, or can the period of reduced hunger also provide an opportunity to develop a healthier relationship with food? The answer may be important for maintaining the benefits of treatment over the long…
Read More